Kennedy Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-23,570
| Closed | -$1.7M | – | 741 |
|
|
2020
Q4 | $1.7M | Sell |
23,570
-340,546
| -94% | -$17.8M | 0.04% | 523 |
|
|
2020
Q3 | $16.6M | Buy |
364,116
+153,591
| +73% | +$6.42M | 0.48% | 20 |
|
|
2020
Q2 | $9.51M | Sell |
210,525
-5,976
| -3% | -$268K | 0.28% | 99 |
|
|
2020
Q1 | $8.34M | Sell |
216,501
-686
| -0.3% | -$31.6K | 0.31% | 71 |
|
|
2019
Q4 | $10.1M | Sell |
217,187
-73,058
| -25% | -$3.16M | 0.25% | 109 |
|
|
2019
Q3 | $11.8M | Sell |
290,245
-10,511
| -3% | -$454K | 0.29% | 80 |
|
|
2019
Q2 | $14.5M | Buy |
300,756
+143,517
| +91% | +$7.54M | 0.34% | 56 |
|
|
2019
Q1 | $9.85M | Sell |
157,239
-160,650
| -51% | -$11M | 0.23% | 126 |
|
|
2018
Q4 | $19M | Sell |
317,889
-106,000
| -25% | -$6.36M | 0.47% | 24 |
|
|
2018
Q3 | $27.3M | Sell |
423,889
-54,272
| -11% | -$3.03M | 0.51% | 14 |
|
|
2018
Q2 | $21.5M | Sell |
478,161
-121,860
| -20% | -$4.86M | 0.4% | 33 |
|
|
2018
Q1 | $18.6M | Buy |
600,021
+458,774
| +325% | +$15.1M | 0.36% | 48 |
|
|
2017
Q4 | $4.22M | Buy |
141,247
+29,741
| +27% | +$861K | 0.08% | 478 |
|
|
2017
Q3 | $3.68M | Buy |
+111,506
| New | +$3.86M | 0.07% | 517 |
|
|
2013
Q3 | – | Sell |
-168,621
| Closed | -$995K | – | 813 |
|
|
2013
Q2 | $995K | Buy |
+168,621
| New | +$567K | 0.02% | 643 |
|
Other funds holding BEAT
Kennedy Capital Management's BEAT Position: Q1 2021 in Review
Kennedy Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 23,570 shares — an estimated $1.7M sold.
Kennedy Capital Management first reported a position in BEAT in Q2 2013 and held it in 15 quarters. The position peaked at $27.3M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Kennedy Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Kennedy Capital Management sold 23,570 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.7M.
- Kennedy Capital Management first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 15 quarters.
- Kennedy Capital Management's BioTelemetry, Inc. position peaked at $27.3M in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Kennedy Capital Management's 13F filing for Q1 2021, filed 14 May 2021.